CEL-SCI prices $5M public offering at 31c per share

CEL-SCI (CVM) announced the pricing of a best-efforts public offering of 16,130,000 shares of its common stock. Each share of common stock is being sold at a public offering price of $0.31 per share. Total gross proceeds from the offering, before deducting the placement agent’s fees and other offering expenses, are expected to be approximately $5,000,000. The offering is expected to close on December 31, 2024, subject to satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering to fund the continued development of Multikine, general corporate purposes, and working capital. ThinkEquity is acting as sole placement agent for the offering

Don't Miss Our New Year's Offers:

• Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
• Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on CVM:

• CEL-SCI announces common stock offering, no amount given
• CEL-SCI provides rationale for use of Multikine in head, neck cancer study
• CEL-SCI, FDA agree on patient selection approach for Multikine study

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.